
Sign up to save your podcasts
Or


A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.

91,297 Listeners

21,954 Listeners

43,687 Listeners

91 Listeners

6,467 Listeners

113,121 Listeners

5 Listeners

56,944 Listeners

0 Listeners

10,331 Listeners

33 Listeners

3,051 Listeners

8,238 Listeners

29,272 Listeners

1,598 Listeners

4,294 Listeners

7 Listeners

632 Listeners

12,559 Listeners